Submit Content
Get the latest delivered to your inbox
Privacy Policy

Novartis

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2012, the Group achieved net sales of USD 56.7 billion, while R&D throughout the Group amounted to approximately USD 9.3 billion (USD 9.1 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 129,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit www.novartis.com.

 

Novartis is on Twitter. Sign up to follow @Novartis at twitter.com/novartis.

    Identification d'une nouvelle cible du paludisme ayant le potentiel de prévenir, bloquer et traiter plusieurs stades du cycle de vie du paludisme Image

    POSTED 

    11-29-13

    Identification d'une nouvelle cible du paludisme ayant le potentiel de prévenir, bloquer et traiter plusieurs stades du cycle de vie du paludisme

    Les chercheurs de Novartis ont découvert une nouvelle cible médicamenteuse pour le traitement du paludisme. La découverte, publiée en ligne dans la revue Nature,2 identifie phosphatidylinositol-4-kinase (PfPI4K) comme cible des imidazopyrazines, une nouvelle classe de molécule...

    Novartis Honored with Outstanding Corporation Award by World Forum for Ethics in Business Image

    POSTED 

    11-15-13

    Novartis Honored with Outstanding Corporation Award by World Forum for Ethics in Business

    The World Forum for Ethics in Business (WFEB) awarded Novartis the Ethics in Business Award in the Outstanding Corporation category. The WFEB is the public interest foundation focused on promoting and defending ethical approaches to business and corporate governance.

    “This award recognizes...

    Novartis Honored by Malaria No More Corporate Citizenship Award in Recognition of Long-standing Commitment to Eliminating the Disease Image

    POSTED 

    11-14-13

    Novartis Honored by Malaria No More Corporate Citizenship Award in Recognition of Long-standing Commitment to Eliminating the Disease

    In recognition of Novartis’ significant on-going contributions to malaria control and elimination, the company has been honored with the Global Corporate Citizenship Award at the Malaria No More International Honors annual benefit.

    Since 2001 Novartis has delivered more than 600 million an...

    Novartis First Company Accredited with Global "CEO Cancer Gold Standard" for Outstanding Efforts in Cancer Prevention and Treatment Image

    POSTED 

    08-08-13

    Novartis First Company Accredited with Global "CEO Cancer Gold Standard" for Outstanding Efforts in Cancer Prevention and Treatment

    Novartis is the first company to earn global CEO Cancer Gold Standard accreditation by the non-profit organization CEO Roundtable on Cancer, a group of cancer fighting CEOs from a variety of industries, including healthcare. The designation recognizes the company’s efforts to pr...

    Novartis Wins GBCHealth Business Action on Health Award For Social Ventures Initiative Image

    POSTED 

    05-17-13

    Novartis Wins GBCHealth Business Action on Health Award For Social Ventures Initiative

    • GBCHealth recognizes Novartis Arogya Parivar (“Healthy Family”) initiative as one of the best corporate programs to address global health needs
    • Arogya Parivar has improved access to medicine for 42 million patients across 33,000 villages in India
    Novartis Sponsored Restoration of Cultural Heritage Landmark in Spain Awarded Laureate in Coveted EU Europa Nostra Award Image

    POSTED 

    04-26-13

    Novartis Sponsored Restoration of Cultural Heritage Landmark in Spain Awarded Laureate in Coveted EU Europa Nostra Award

    Novartis announced today that its Abadia Retuerta Abbey property, which has been under restoration since 2006, was recognized as one of the 15 best building conservation projects by the prestigious European Union Prize for Cultural Heritage/Europa Nostra. Architect Marco Serra led the project whi...

    Novartis Signs on to Support Malaria No More's Power of One Campaign to Stride Towards a Future Without Malaria Image

    POSTED 

    04-25-13

    Novartis Signs on to Support Malaria No More's Power of One Campaign to Stride Towards a Future Without Malaria

    Novartis and Malaria No More, a leading global charity determined to end malaria deaths, announced today that they are joining forces on the Power of One campaign to help close the treatment gap and accelerate progress in the fight against malaria. Over the next three years, Novartis will support...

    More Than 16,500 Novartis Associates Worldwide Engage in Voluntary Activities For Community Partnership Day Image

    POSTED 

    04-25-13

    More Than 16,500 Novartis Associates Worldwide Engage in Voluntary Activities For Community Partnership Day

    Today more than 16,500 Novartis associates in 56 countries are engaging in voluntary activities to help their local communities in celebration of the company’s 17th Community Partnership Day (CPD). This annual event commemorates the 1996 creation of Novartis as a global leader in healt...

    University of Cape Town and Novartis Collaboration Helps African-based  Scientists Tackle African Diseases, Starting with Tuberculosis and Malaria  Image

    POSTED 

    02-28-13

    University of Cape Town and Novartis Collaboration Helps African-based Scientists Tackle African Diseases, Starting with Tuberculosis and Malaria

    The University of Cape Town (UCT) and the Novartis Institutes for BioMedical Research (NIBR) are working together to bridge the gap between basic science and clinical research to advance innovative medicines that treat African patients. 

    The collaboration with the University’s Drug Discove...

    Novartis Collaboration Aims to Eliminate Rheumatic Heart Disease (RHD) in Zambia, Africa    Image

    POSTED 

    02-28-13

    Novartis Collaboration Aims to Eliminate Rheumatic Heart Disease (RHD) in Zambia, Africa

    • RHD has been eliminated in most developed nations, but sub-Saharan Africa studies show at least 2-3% of school-age children suffer from this often fatal disease1
       

    • Collaboration between Novartis physicians, Zambian healt...
    Novartis Logo

    Novartis

    Novartis

    Join today and get the latest delivered to your inbox